Personalis, Inc.·4

Jun 26, 7:49 PM ET

Hall Christopher M 4

4 · Personalis, Inc. · Filed Jun 26, 2026

Research Summary

AI-generated summary of this filing

Updated

Personalis (PSNL) CEO Christopher Hall Sells 100,000 Shares

What Happened

  • Christopher M. Hall, CEO of Personalis, exercised option shares and sold 100,000 common shares on June 26, 2026. He exercised 100,000 options at $1.61 per share (cost $161,000) and sold 100,000 shares in the open market at a weighted average price of $13.15 per share (gross proceeds ~$1,315,000). The Form 4 also reports a separate 100,000-share option exercise/conversion reported at $0.00 consideration.

Key Details

  • Transaction date: 2026-06-26.
  • Option exercise (acquired): 100,000 shares @ $1.61 = $161,000.
  • Open-market sale (disposed): 100,000 shares @ weighted avg $13.15 = $1,315,000; sale price range $13.00–$13.36 per share (see footnote).
  • Additional derivative conversion (disposed): 100,000 shares @ $0.00 (reported as derivative activity).
  • Plan/authorization: Sales and option exercises were executed under a Rule 10b5-1 trading plan adopted Dec 17, 2025 (footnote F1).
  • Vesting note: Options vested over a three‑year period beginning April 15, 2024 (1/36th monthly) per footnote F3.
  • Shares owned after the transactions: not provided in the excerpt of the filing.
  • Timeliness: Form filed on 2026-06-26 (same day); no late filing indicated.

Context

  • The sequence — exercising options and then selling the same number of shares — is a common insider action that converts optioned shares into publicly traded stock (often executed under a pre-established trading plan). This filing reports sales rather than purchases; purchases generally carry more direct bullish signal for investors.
  • Footnote provides sale price range and states the filer will disclose exact per-price quantities if requested by the SEC, issuer, or a shareholder.

Insider Transaction Report

Form 4
Period: 2026-06-26
Hall Christopher M
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-06-26$1.61/sh+100,000$161,000335,986 total
  • Sale

    Common Stock

    [F1][F2]
    2026-06-26$13.15/sh100,000$1,315,000235,986 total
  • Exercise/Conversion

    Stock Option (right to buy)

    [F1][F3]
    2026-06-26100,000200,000 total
    Exercise: $1.61Exp: 2034-03-15Common Stock (100,000 underlying)
Footnotes (3)
  • [F1]The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2025.
  • [F2]The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $13.00 to $13.36 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  • [F3]The option vested and became exercisable over the three-year period commencing April 15, 2024, with 1/36th of the shares subject to the option vesting each month of continuous service thereafter.
Signature
/s/ Aaron Tachibana, Attorney-in-Fact|2026-06-26

Documents

1 file
  • 4
    form4-06262026_110649.xmlPrimary